Beta Bionics

Beta Bionics is a clinical-stage medical technology company focused on the design, development, and commercialization of its iLet® Bionic Pancreas System. The iLet Bionic Pancreas is designed to autonomously calculate and manage doses of insulin or glucagon using adaptive, self-learning control algorithms, along with continuous glucose monitoring and pump technology, mimicking the body's natural ability to maintain tight blood glucose control.